Personalized Medicine and the Practice of Medicine in the 21st Century

This publication has 21 references indexed in Scilit:

• Effect ofVKORC1Haplotypes on Transcriptional Regulation and Warfarin Dose
  New England Journal of Medicine, 2005
• A systematic review of cost-effectiveness analyses of pharmacogenomic interventions
  Pharmacogenomics, 2004
• Basic science going clinical: molecularly targeted therapy of chronic myelogenous leukemia
  Journal of Cancer Research and Clinical Oncology, 2004
• Pharmacogenomic Profiling in Postmarketing Surveillance: Prospects and Challenges
  Pharmacogenomics, 2003
• Antibody-based therapeutics in oncology
  Expert Review of Anticancer Therapy, 2003
• Gleevec™ for the Treatment of Chronic Myelogenous Leukemia: U.S. Food and Drug Administration Regulatory Mechanisms, Accelerated Approval, and Orphan Drug Status
  The Oncologist, 2002
• Ethical perspectives on pharmacogenomic profiling in the drug development process
  Nature Reviews Drug Discovery, 2002
• Potential Role of Pharmacogenomics in Reducing Adverse Drug Reactions
  JAMA, 2001
• APPLICATIONS OF PHARMACOGENETICS TO DRUG DEVELOPMENT: THE GLAXO WELLCOME EXPERIENCE^*
  Drug Metabolism Reviews, 2000
• Space-Time Relationships in Somesthetic Localization
  Science, 1956